Kiniksa Pharmaceuticals, Ltd. (KNSA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 594.17M | 527.18M | 475.53M | 420.31M | 355.91M | 331.8M | 311.3M | 301.02M | 270.59M | 276.3M | 256.11M | 246.04M |
| Cash & Short-Term Investments | 468.09M | 414.07M | 352.1M | 307.78M | 268.34M | 243.63M | 223.78M | 218.76M | 213.55M | 206.37M | 201.08M | 184.99M |
| Cash Only | 189.95M | 165.6M | 174.86M | 192.04M | 157.13M | 183.58M | 97.38M | 99.27M | 141.08M | 107.95M | 117.83M | 112.57M |
| Short-Term Investments | 278.14M | 248.48M | 177.24M | 115.75M | 111.21M | 60.05M | 126.4M | 119.49M | 72.47M | 98.42M | 83.26M | 72.42M |
| Accounts Receivable | 0 | 15.59M | 51.74M | 31.91M | 40.06M | 41.72M | 24.89M | 20.45M | 15.99M | 21.27M | 3.04M | 24.65M |
| Days Sales Outstanding | - | 15.32 | 21.28 | 20.89 | 26.71 | 25.01 | 18.59 | 15.27 | 21.23 | 13.41 | 19 | 20.42 |
| Inventory | 0 | 54.9M | 41.4M | 48.18M | 22.07M | 26.36M | 28.68M | 34.86M | 27.28M | 31.12M | 25.58M | 23.96M |
| Days Inventory Outstanding | - | 48.62 | 49.29 | 45.01 | 35.35 | 38.26 | 59.15 | 66.59 | 84.25 | 97.48 | 83.18 | 94.78 |
| Other Current Assets | 126.08M | 42.61M | 30.29M | 32.44M | 25.43M | 20.08M | 33.95M | 26.95M | 13.77M | 17.54M | 26.4M | 12.44M |
| Total Non-Current Assets | 231.11M | 236.46M | 236.8M | 240.84M | 243.42M | 248.75M | 244M | 241.41M | 249.08M | 250.03M | 226.95M | 238.29M |
| Property, Plant & Equipment | 0 | 11.75M | 11.73M | 11.38M | 11.06M | 11.04M | 11.66M | 12.4M | 13.04M | 12.66M | 13.59M | 14.33M |
| Fixed Asset Turnover | - | 17.22x | 15.65x | 13.98x | 12.47x | 10.80x | 9.33x | 8.54x | 6.21x | 6.35x | 4.80x | 6.82x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 15M | 15.25M | 15.5M | 15.75M | 16M | 16.25M | 16.5M | 16.75M | 17M | 17.25M | 17.5M | 17.75M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 216.11M | 11.31M | 8.29M | 8.2M | 8.2M | 10.31M | 7.85M | 7.9M | 4.13M | 827K | 2.29M | 2.35M |
| Total Assets | 825.28M | 763.63M | 712.33M | 661.15M | 599.33M | 580.55M | 555.3M | 542.43M | 519.67M | 526.32M | 483.06M | 484.33M |
| Asset Turnover | 0.27x | 0.27x | 0.26x | 0.25x | 0.23x | 0.22x | 0.20x | 0.20x | 0.15x | 0.17x | 0.14x | 0.15x |
| Asset Growth % | 37.7% | 31.54% | 28.28% | 21.89% | 15.33% | 10.3% | 14.95% | 12% | 17.34% | 14.5% | 5.02% | 130% |
| Total Current Liabilities | 156.61M | 139.18M | 123.59M | 117.83M | 97.27M | 100.62M | 95.95M | 84.29M | 64.21M | 63.67M | 53.47M | 47.47M |
| Accounts Payable | 0 | 2.03M | 6.15M | 8.96M | 1.98M | 2.04M | 8.33M | 7.39M | 5.63M | 8.25M | 1.01M | 648K |
| Days Payables Outstanding | - | 4.13 | 8.31 | 7.01 | 2.93 | 7.21 | 14.63 | 13.96 | 20.02 | 15.91 | 2.79 | 4.08 |
| Short-Term Debt | 3.17M | 2.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 31.81M | 0 | 31.81M | 0 | 0 | 0 | 12K | 156K | 307K | 2.56M | 4.67M |
| Other Current Liabilities | 153.44M | 102.36M | 37.56M | -628K | 25.89M | 33.12M | 29.15M | 22.97M | 18.74M | 36.91M | 18.7M | 13.84M |
| Current Ratio | 3.79x | 3.79x | 3.85x | 3.57x | 3.66x | 3.30x | 3.24x | 3.57x | 4.21x | 4.34x | 4.79x | 5.18x |
| Quick Ratio | 3.79x | 3.39x | 3.51x | 3.16x | 3.43x | 3.04x | 2.95x | 3.16x | 3.79x | 3.85x | 4.31x | 4.68x |
| Cash Conversion Cycle | - | 59.82 | 62.26 | 58.88 | 59.13 | 56.06 | 63.1 | 67.9 | 85.46 | 94.97 | 99.39 | 111.12 |
| Total Non-Current Liabilities | 62.98M | 56.84M | 53.36M | 48.32M | 44.57M | 41.5M | 22.34M | 23.04M | 23.57M | 23.82M | 24.47M | 25.2M |
| Long-Term Debt | 5.86M | 6.51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 7.02M | 7.24M | 7.62M | 7.86M | 8.56M | 9.32M | 9.86M | 10.01M | 10.65M | 11.28M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 57.13M | 50.33M | 14.53M | 9.26M | 5.14M | 1.82M | 1.96M | 1.93M | 1.89M | 1.86M | 1.95M | 1.92M |
| Total Liabilities | 219.59M | 196.03M | 176.95M | 166.14M | 141.84M | 142.12M | 118.29M | 107.33M | 87.78M | 87.48M | 77.94M | 72.68M |
| Total Debt | 9.03M | 9.5M | 9.72M | 9.77M | 9.91M | 9.86M | 10.6M | 11.4M | 12.14M | 12.26M | 12.96M | 13.52M |
| Net Debt | -180.93M | -156.1M | -165.14M | -182.27M | -147.22M | -173.73M | -86.78M | -87.87M | -128.94M | -95.7M | -104.86M | -99.05M |
| Debt / Equity | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x |
| Debt / EBITDA | 0.31x | 0.47x | 0.40x | 0.48x | 0.73x | - | - | 36.43x | - | 38.67x | - | - |
| Net Debt / EBITDA | -6.18x | -7.71x | -6.77x | -8.88x | -10.81x | - | - | -280.73x | - | -301.88x | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | 1.34x | - | - |
| Total Equity | 605.69M | 567.61M | 535.38M | 495.01M | 457.49M | 438.44M | 437.01M | 435.1M | 431.89M | 438.84M | 405.13M | 411.66M |
| Equity Growth % | 32.39% | 29.46% | 22.51% | 13.77% | 5.93% | -0.09% | 7.87% | 5.69% | 10.72% | 10.78% | 5.5% | 168.19% |
| Book Value per Share | 7.35 | 7.19 | 6.86 | 6.35 | 6.01 | 6.06 | 6.09 | 6.13 | 6.11 | 6.04 | 5.77 | 5.75 |
| Total Shareholders' Equity | 605.69M | 567.61M | 535.38M | 495.01M | 457.49M | 438.44M | 437.01M | 435.1M | 431.89M | 438.84M | 405.13M | 411.66M |
| Common Stock | 21K | 21K | 21K | 21K | 20K | 20K | 20K | 20K | 20K | 20K | 20K | 19K |
| Retained Earnings | -439.55M | -462.14M | -476.34M | -494.77M | -512.6M | -521.14M | -512.25M | -499.56M | -495.65M | -477.95M | -503.19M | -489.33M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -665K | -25K | -155K | -53K | -165K | -163K | -41K | -130K | -53K | 6K | -1K | 13K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |